Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We would like to congratulate Dr Audrey Gérard on her three-year Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Award. The award will allow Audrey to examine how the behaviour of killer T cells is coordinated to optimise immunity against pathogens and tumour growth.

Dr Audrey Gérard in her lab at the Kennedy Institute.

Killer CD8 T cells attack infected or mutated cells to protect against pathogens and tumour growth. There are many different CD8 T cell clones in the body – only a fraction of these recognise the same target and the amount of protection offered by each clone varies.

Audrey's group uses state-of-the-art imaging approaches to understand how CD8 T cell clones talk to each other during an immune response. Their work will determine how different clones coordinate their activity to rapidly clear infection and establish long-term immunity, while limiting damage to the body's own tissues. This information may guide the development of better vaccines, such as against influenza infection.

"This award is an amazing opportunity for me to tackle this project, which aims to study how CD8 T cells organise themselves as an ecosystem during healthy responses. I believe it will give a different perspective on our understanding of immune response coordination and regulation", said Dr Gérard.

Director of Research at the Kennedy Institute, Professor Michael Dustin, said: "This award recognises Audrey's fundamental work in immunobiology, laying the foundation for future cures."

Audrey joined the Kennedy Institute in 2016 as a Senior Research Fellow funded by the Kennedy Trust for Rheumatology Research.

Funding

BBSRC logo

 

 

 

Similar stories

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.